Inhibition of Id proteins by a peptide aptamer induces cell-cycle arrest and apoptosis in ovarian cancer cells

por Mern, D S, Hasskarl, J, Burwinkel, B
Publicado 2010

Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation

por de Plater, L, Laugé, A, Guyader, C, Poupon, M-F, Assayag, F, de Cremoux, P, Vincent-Salomon, A, Stoppa-Lyonnet, D, Sigal-Zafrani, B, Fontaine, J-J, Brough, R, Lord, C J, Ashworth, A, Cottu, P, Decaudin, D, Marangoni, E
Publicado 2010

Beclin 1 over- and underexpression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxia

por Koukourakis, M I, Giatromanolaki, A, Sivridis, E, Pitiakoudis, M, Gatter, K C, Harris, A L
Publicado 2010

Dose-finding study and pharmacogenomic analysis of fixed-rate infusion of gemcitabine, irinotecan and bevacizumab in pretreated metastatic colorectal cancer patients

por Abajo, A, Rodriguez, J, Bitarte, N, Zarate, R, Boni, V, Ponz, M, Chopitea, A, Bandres, E, Garcia-Foncillas, J
Publicado 2010

Immunomodulation with dendritic cells and donor lymphocyte infusion converge to induce graft vs neuroblastoma reactions without GVHD after allogeneic bone marrow transplantation

por Ash, S, Stein, J, Askenasy, N, Yaniv, I
Publicado 2010

Elastin-derived peptides enhance melanoma growth in vivo by upregulating the activation of Mcol-A (MMP-1) collagenase

por Devy, J, Duca, L, Cantarelli, B, Joseph-Pietras, D, Scandolera, A, Rusciani, A, Parent, L, Thevenard, J, Pasco, S Brassart, Tarpin, M, Martiny, L, Debelle, L
Publicado 2010

Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial

por Garufi, C, Torsello, A, Tumolo, S, Ettorre, G M, Zeuli, M, Campanella, C, Vennarecci, G, Mottolese, M, Sperduti, I, Cognetti, F
Publicado 2010

Phase Ib study of CP-868,596, a PDGFR inhibitor, combined with docetaxel with or without axitinib, a VEGFR inhibitor

por Michael, M, Vlahovic, G, Khamly, K, Pierce, K J, Guo, F, Olszanski, A J
Publicado 2010

Skin cancer screening behaviours among individuals with a strong family history of malignant melanoma

por Kasparian, N A, McLoone, J K, Meiser, B, Butow, P N, Simpson, J M, Mann, G J
Publicado 2010

Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapy

por Hong, A M, Dobbins, T A, Lee, C S, Jones, D, Harnett, G B, Armstrong, B K, Clark, J R, Milross, C G, Kim, J, O'Brien, C J, Rose, B R
Publicado 2010

Anthracycline rechallenge using pegylated liposomal doxorubicin in patients with metastatic breast cancer: a pooled analysis using individual data from four prospective trials

por Al-Batran, S-E, Güntner, M, Pauligk, C, Scholz, M, Chen, R, Beiss, B, Stopatschinskaja, S, Lerbs, W, Harbeck, N, Jäger, E
Publicado 2010

Role of human tissue kallikrein in gastrointestinal stromal tumour invasion

por Dominek, P, Campagnolo, P, H-Zadeh, M, Kränkel, N, Chilosi, M, Sharman, J A, Caporali, A, Mangialardi, G, Spinetti, G, Emanueli, C, Pignatelli, M, Madeddu, P
Publicado 2010

Serum cytokine concentrations, flavonol intake and colorectal adenoma recurrence in the Polyp Prevention Trial

por Bobe, G, Murphy, G, Albert, P S, Sansbury, L B, Lanza, E, Schatzkin, A, Colburn, N H, Cross, A J
Publicado 2010

A Phase Ib dose-escalation study to evaluate safety and tolerability of the addition of the aminopeptidase inhibitor tosedostat (CHR-2797) to paclitaxel in patients with advanced s...

por van Herpen, C M L, Eskens, F A L M, de Jonge, M, Desar, I, Hooftman, L, Bone, E A, Timmer-Bonte, J N H, Verweij, J
Publicado 2010

Addition of GM-CSF to trastuzumab stabilises disease in trastuzumab-resistant HER2+ metastatic breast cancer patients

por Cheng, Y C, Valero, V, Davis, M L, Green, M C, Gonzalez-Angulo, A M, Theriault, R L, Murray, J L, Hortobagyi, G N, Ueno, N T
Publicado 2010

Identification of serum angiopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapy

por Goede, V, Coutelle, O, Neuneier, J, Reinacher-Schick, A, Schnell, R, Koslowsky, T C, Weihrauch, M R, Cremer, B, Kashkar, H, Odenthal, M, Augustin, H G, Schmiegel, W, Hallek, M, Hacker, U T
Publicado 2010

Activity of irinotecan and temozolomide in the presence of O(6)-methylguanine-DNA methyltransferase inhibition in neuroblastoma pre-clinical models

por Cai, W, Maldonado, N V, Cui, W, Harutyunyan, N, Ji, L, Sposto, R, Reynolds, C P, Keshelava, N
Publicado 2010

A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients

por Lesterhuis, W J, de Vries, I J M, Aarntzen, E A, de Boer, A, Scharenborg, N M, van de Rakt, M, van Spronsen, D-J, Preijers, F W, Figdor, C G, Adema, G J, Punt, C J A
Publicado 2010

Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancer

por Conroy, T, Yataghène, Y, Etienne, P L, Michel, P, Senellart, H, Raoul, J L, Mineur, L, Rives, M, Mirabel, X, Lamezec, B, Rio, E, Le Prisé, E, Peiffert, D, Adenis, A
Publicado 2010

Bcl-2 and β(1)-integrin predict survival in a tissue microarray of small cell lung cancer

por Lawson, M H, Cummings, N M, Rassl, D M, Vowler, S L, Wickens, M, Howat, W J, Brenton, J D, Murphy, G, Rintoul, R C
Publicado 2010